Nonprofit Medicines360 Provides Affordable Contraception, Women’s Health
Executive Summary
Emerging Company Profile: Medicines360 and partner Allergan launched the IUD Liletta in 2015, so now the nonprofit pharmaceutical company is looking for additional contraceptives and women’s health products.
You may also be interested in...
Keeping Track: New Indication For Lucentis; New Lesinurad Application From Ironwood
The latest drug development news and highlights from our FDA Performance Tracker.
Long-Acting Reversible Contraceptives Await “Obamacare” Boost
Contraception coverage mandated by the Affordable Care Act could unlock demand for IUDs. Actavis aims to provide an alternative to Bayer’s hormone-eluting IUD in 2014; public sector rights to Levosert are assigned to nonprofit Medicines360.